Dr Rebecca Harris
Rebecca Harris is the Drug Discovery Programme Manager at the Milner Therapeutics Institute, and in this role has responsibilities as Programme Manager for the Onco-Innovation Programme.
The Milner Therapeutics Institute at the University of Cambridge represents a new paradigm, dedicated to the conversion of groundbreaking science into therapies. Its mission since 2015 has been delivered through three distinct avenues: connecting academia with industry through a global therapeutic alliance; enabling collaborative research projects; and accelerating new biotech companies.
Prior to joining the Milner Therapeutics Institute in July 2018, Rebecca worked in both academic and industry settings, including the Wellcome Sanger Institute, Horizon Discovery, Ferring Research Ltd, the University of Birmingham and the University of Chicago. Her PhD focused on DNA repair mechanisms within Testicular Cancer.